IOL Chemicals

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE485C01029
  • NSEID: IOLCP
  • BSEID: 524164
INR
128.20
3.3 (2.64%)
BSENSE

Jun 18

BSE+NSE Vol: 22.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 250603,
    "name": "IOL Chemicals",
    "stock_name": "IOL Chemicals",
    "full_name": "IOL Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/iol-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "128.20",
    "chg": 3.3,
    "chgp": "2.64%",
    "dir": 1,
    "prev_price": "124.90",
    "mcapval": "3,763.02 Cr",
    "mcap": "Small Cap",
    "scripcode": 524164,
    "symbol": "IOLCP",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE485C01029",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "22.11 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/iol-chemicals-250603-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts IOL Chemicals & Pharmaceuticals Ltd to 52-Week High of Rs 126.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-hits-new-52-week-high-at-rs12687-4003139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_priceRelatedfactors_4003139.png",
        "date": "2026-05-21 13:10:17",
        "description": "With a decisive surge to Rs 126.87 on 21 May 2026, IOL Chemicals & Pharmaceuticals Ltd has reached a fresh 52-week high, marking a remarkable 42.38% gain over the past year against the Sensex’s decline of 7.94%. This rally is underpinned by a confluence of bullish technical indicators and sustained price momentum, setting the stock apart in a challenging market environment."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/iol-chemicals-pharmaceuticals-ltd-is-rated-hold-4002888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_mojoScore_4002888.png",
        "date": "2026-05-21 10:10:05",
        "description": "IOL Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-reports-very-positive-quarterly-financial-performance-4001942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_fintrenddot_4001942.png",
        "date": "2026-05-21 08:00:06",
        "description": "IOL Chemicals & Pharmaceuticals Ltd has delivered a standout quarterly performance for March 2026, marking a significant improvement in its financial trend and market returns. The company’s latest results reveal record-breaking revenue and profit metrics, driving an upgrade in its Mojo Grade from Sell to Hold and signalling renewed investor confidence amid a challenging sector backdrop."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd Surges 7.3% to Day's High of Rs 119 — Outperforms Sector by 4.96 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-hits-intraday-high-with-73-surge-on-20-may-2026-4001187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_priceRelatedfactors_4001187.png",
        "date": "2026-05-20 15:01:13",
        "description": "The Sensex edged up 0.26% after a volatile session, but IOL Chemicals & Pharmaceuticals Ltd stole the spotlight with a robust 7.3% gain, reaching an intraday high of Rs 119. This 4.96 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum surge."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd Surges 7.07% to Day's High of Rs 104.4 — Outperforms Sector by 7.13 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-hits-intraday-high-with-707-surge-3985601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_priceRelatedfactors_3985601.png",
        "date": "2026-05-11 11:30:54",
        "description": "While the Sensex declined by 1.16% on 11 May 2026, IOL Chemicals & Pharmaceuticals Ltd surged 7.07%, reaching an intraday high of Rs 104.4. This 7.13 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally amid a broadly weak market environment."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Price Attractiveness Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-valuation-shifts-signal-price-attractiveness-challenges-3984489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_valuationdot_3984489.png",
        "date": "2026-05-11 08:00:24",
        "description": "IOL Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns over recent periods. This recalibration in price attractiveness, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, invites a closer examination of the stock’s current standing relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/iol-chemicals-pharmaceuticals-ltd-is-rated-hold-3984020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IOLChemicalsPha_mojoScore_3984020.png",
        "date": "2026-05-10 10:10:26",
        "description": "IOL Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-valuation-shifts-signal-price-attractiveness-change-3969317",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IOLChemicalsPha_valuationdot_3969317.png",
        "date": "2026-04-30 08:00:10",
        "description": "IOL Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive category. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a significant alteration in the stock’s price attractiveness relative to its historical averages and peer group. Investors and analysts are now reassessing the company’s market positioning amid these valuation adjustments."
      },
      {
        "title": "IOL Chemicals & Pharmaceuticals Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/iol-chemicals-pharmaceuticals-ltd-shows-mixed-technical-signals-amid-mildly-bullish-momentum-3967381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IOLChemicalsPha_technicaldot_3967381.png",
        "date": "2026-04-29 08:00:39",
        "description": "IOL Chemicals & Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum from sideways to mildly bullish. Despite a day-on-day price decline of 1.59%, the stock’s technical indicators present a nuanced picture, with some suggesting upward potential while others remain cautious. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors."
      }
    ],
    "total": 15,
    "sid": "250603",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/iol-chemicals-pharmaceuticals-250603"
  },
  "announcements": [
    {
      "caption": "Communication To Shareholders Relating To Unclaimed Dividend",
      "datetime": "11-Jun-2026",
      "details": "Intimation regarding communication to shareholders relating to unclaimed dividend",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "10-Jun-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "28-May-2026",
      "details": "Earning call transcript",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "IOL Chemicals & Pharmaceuticals Ltd has declared <strong>50%</strong> dividend, ex-date: 17 Feb 26",
          "dt": "2026-02-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "IOL Chemicals & Pharmaceuticals Ltd has announced <strong>2:10</strong> stock split, ex-date: 11 Mar 25",
          "dt": "2025-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Communication To Shareholders Relating To Unclaimed Dividend

11-Jun-2026 | Source : BSE

Intimation regarding communication to shareholders relating to unclaimed dividend

Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015

10-Jun-2026 | Source : BSE

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

28-May-2026 | Source : BSE

Earning call transcript

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

IOL Chemicals & Pharmaceuticals Ltd has declared 50% dividend, ex-date: 17 Feb 26

stock-summary
SPLITS

IOL Chemicals & Pharmaceuticals Ltd has announced 2:10 stock split, ex-date: 11 Mar 25

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available